Satsuma Pharmaceuticals Inc (STSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2017 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | N/A | 545,435 | 331,550 | 491,228 | 427,264 |
| Other current assets | 0 | -545,435 | -331,550 | -491,228 | -427,264 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Non-Current Assets | |||||
| PPE Net | N/A | 101,610 | 93,850 | 84,015 | 81,094 |
| Intangibles | 0 | 127,679 | 74,069 | 35,180 | 37,533 |
| Other Non-Current Assets | 0 | -229,289 | -167,919 | -119,195 | -118,627 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $N/A | $10,319,250 | $9,236,910 | $9,193,237 | $9,493,169 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accrued Expenses | N/A | 100,947 | 141,150 | 99,625 | 109,128 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 245,299 | 245,294 | 245,290 | 245,285 |
| Other Non-Current Liabilities | 0 | -245,299 | -245,294 | -245,290 | -245,285 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $N/A | $9,103,302 | $8,018,987 | $8,314,680 | $8,722,402 |
| Shareholders' Equity | |||||
| Common Shares | N/A | 1,972,457 | 1,968,025 | 1,964,234 | 1,960,871 |
| Retained earnings | N/A | -776,367 | -810,814 | -1,146,792 | -1,185,925 |
| Other shareholders' equity | 0 | 19,857 | 60,712 | 61,115 | -4,179 |
| TOTAL | $N/A | $1,215,947 | $1,217,923 | $878,557 | $770,767 |
| Total Liabilities And Equity | $0 | $10,319,249 | $9,236,910 | $9,193,237 | $9,493,169 |